Current Body Mass Index Is Associated with Reported Weight Gain as a Reason for Discontinuing Oral Contraceptive Pill Use
Obesities · 29.03.2026 · 6 (2) · 20
DOI: 10.3390/obesities6020020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesities, online erschienen am 29.03.2026. Verfasst von Adnin Zaman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Concerns about weight gain are commonly cited with combined oral contraceptive pill (COCP) use, yet it remains unclear whether perceived weight gain as a reason for discontinuation differs by body mass index (BMI). We analyzed data from the 2017–2019 National Survey of Family Growth (NSFG), including 3709 non-pregnant women aged 20–49 years who had ever used COCPs and had BMI calculated from self-reported height and weight. Trained NSFG staff interviewed participants on reasons for discontinuation and coded them into predefined categories, including weight gain. Discontinuation was examined by BMI category (underweight, normal weight, overweight, obesity) using survey-weighted logistic regression adjusted for demographic and socioeconomic covariates. Overall, 35.2% (95% CI 32.3–38.1%) of women reported discontinuing COCPs due to dissatisfaction, with 20.2% (95% CI 18.1–22.3%) citing side effects. Weight gain was reported by 7.0% (95% CI 5.6–8.4%) of ever-users, with higher prevalence among women with overweight (8.4%) and obesity (7.7%) compared with normal-weight women (5.5%). In adjusted analyses, women with overweight (aOR 1.76, p = 0.048) and obesity (aOR 1.68, p = 0.033) had higher odds of COCP discontinuation due to self-reported weight gain. These findings highlight the importance of addressing weight-related concerns during contraceptive counseling, particularly for women with higher BMI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA.
- Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.
- School of Nursing, University of Rochester, Rochester, NY 14642, USA.
- Wegmans School of Health and Nutrition, Rochester Institute of Technology, Rochester, NY 14623, USA.
- Department of Obstetrics and Gynecology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
ORCID-Profile: Adnin Zaman, Myla Strawderman, Susan W Groth, Barbara Lohse, Roland J Thorpe, Elizabeth Heitman
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
Zitieren
APA
Zaman, A., Strawderman, M., Groth, S. W., Lohse, B., Vitek, W., Thorpe, R. J., & Heitman, E. (2026). Current Body Mass Index Is Associated with Reported Weight Gain as a Reason for Discontinuing Oral Contraceptive Pill Use. Obesities, 6(2), 20. https://doi.org/10.3390/obesities6020020
Vancouver
Zaman A, Strawderman M, Groth SW, Lohse B, Vitek W, Thorpe RJ, et al. Current Body Mass Index Is Associated with Reported Weight Gain as a Reason for Discontinuing Oral Contraceptive Pill Use. Obesities. 2026;6(2):20. doi:10.3390/obesities6020020
BibTeX
@article{Zaman2026,
author = {Zaman, Adnin and Strawderman, Myla and Groth, Susan W and Lohse, Barbara and Vitek, Wendy and Thorpe, Roland J and Heitman, Elizabeth},
title = {Current Body Mass Index Is Associated with Reported Weight Gain as a Reason for Discontinuing Oral Contraceptive Pill Use},
journal = {Obesities},
year = {2026},
volume = {6},
number = {2},
pages = {20},
doi = {10.3390/obesities6020020}
}
EUVIMED